nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluridine—Keratopathy—Vandetanib—thyroid cancer	0.194	0.65	CcSEcCtD
Trifluridine—Zidovudine—TERT—thyroid cancer	0.045	1	CrCbGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CCDC6—thyroid cancer	0.0385	0.103	CbGpPWpGaD
Trifluridine—TK1—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.0351	0.0937	CbGpPWpGaD
Trifluridine—TK1—thyroid gland—thyroid cancer	0.0338	0.153	CbGeAlD
Trifluridine—TK1—head—thyroid cancer	0.03	0.136	CbGeAlD
Trifluridine—TYMP—saliva-secreting gland—thyroid cancer	0.0295	0.134	CbGeAlD
Trifluridine—TYMS—Erlotinib—Vandetanib—thyroid cancer	0.0273	0.449	CbGdCrCtD
Trifluridine—TYMP—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.0243	0.065	CbGpPWpGaD
Trifluridine—Dry eye—Vandetanib—thyroid cancer	0.0243	0.0812	CcSEcCtD
Trifluridine—TYMP—trachea—thyroid cancer	0.0228	0.103	CbGeAlD
Trifluridine—TK1—lymph node—thyroid cancer	0.021	0.095	CbGeAlD
Trifluridine—TYMS—G1/S-Specific Transcription—CDK1—thyroid cancer	0.0205	0.0547	CbGpPWpGaD
Trifluridine—TYMP—thyroid gland—thyroid cancer	0.018	0.0815	CbGeAlD
Trifluridine—TK1—E2F transcription factor network—CDK1—thyroid cancer	0.018	0.0481	CbGpPWpGaD
Trifluridine—TYMS—Afatinib—Vandetanib—thyroid cancer	0.0179	0.294	CbGdCrCtD
Trifluridine—TYMP—head—thyroid cancer	0.016	0.0723	CbGeAlD
Trifluridine—TYMS—Gefitinib—Vandetanib—thyroid cancer	0.0156	0.257	CbGdCrCtD
Trifluridine—TYMS—thyroid gland—thyroid cancer	0.0154	0.0699	CbGeAlD
Trifluridine—TYMP—Bladder Cancer—BRAF—thyroid cancer	0.0141	0.0377	CbGpPWpGaD
Trifluridine—TYMS—head—thyroid cancer	0.0137	0.062	CbGeAlD
Trifluridine—TYMS—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.0124	0.0332	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—TERT—thyroid cancer	0.0122	0.0325	CbGpPWpGaD
Trifluridine—TYMS—E2F mediated regulation of DNA replication—CDK1—thyroid cancer	0.012	0.0322	CbGpPWpGaD
Trifluridine—TYMP—lymph node—thyroid cancer	0.0112	0.0506	CbGeAlD
Trifluridine—Vision blurred—Vandetanib—thyroid cancer	0.0108	0.0362	CcSEcCtD
Trifluridine—TYMP—Bladder Cancer—CCND1—thyroid cancer	0.0103	0.0275	CbGpPWpGaD
Trifluridine—TYMS—lymph node—thyroid cancer	0.0096	0.0434	CbGeAlD
Trifluridine—TK1—Fluoropyrimidine Activity—TP53—thyroid cancer	0.00931	0.0249	CbGpPWpGaD
Trifluridine—Stinging—Epirubicin—thyroid cancer	0.00809	0.027	CcSEcCtD
Trifluridine—Pain—Vandetanib—thyroid cancer	0.00802	0.0268	CcSEcCtD
Trifluridine—Stinging—Doxorubicin—thyroid cancer	0.00749	0.025	CcSEcCtD
Trifluridine—TYMP—Bladder Cancer—TP53—thyroid cancer	0.00678	0.0181	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—NKX2-1—thyroid cancer	0.00649	0.0174	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—HRAS—thyroid cancer	0.00649	0.0173	CbGpPWpGaD
Trifluridine—TYMP—Fluoropyrimidine Activity—TP53—thyroid cancer	0.00645	0.0173	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—CDK1—thyroid cancer	0.00637	0.017	CbGpPWpGaD
Trifluridine—TK1—Metabolism—MINPP1—thyroid cancer	0.00618	0.0165	CbGpPWpGaD
Trifluridine—Dry eye—Epirubicin—thyroid cancer	0.00606	0.0202	CcSEcCtD
Trifluridine—Dry eye—Doxorubicin—thyroid cancer	0.0056	0.0187	CcSEcCtD
Trifluridine—Nausea—Vandetanib—thyroid cancer	0.00557	0.0186	CcSEcCtD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CDK1—thyroid cancer	0.00554	0.0148	CbGpPWpGaD
Trifluridine—Pain—Sorafenib—thyroid cancer	0.00541	0.0181	CcSEcCtD
Trifluridine—TK1—Metabolism—NDUFA13—thyroid cancer	0.00525	0.014	CbGpPWpGaD
Trifluridine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.00508	0.0136	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CHST14—thyroid cancer	0.00494	0.0132	CbGpPWpGaD
Trifluridine—Hypersensitivity—Sorafenib—thyroid cancer	0.00466	0.0156	CcSEcCtD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—TP53—thyroid cancer	0.00463	0.0124	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—CDK1—thyroid cancer	0.00463	0.0124	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—MINPP1—thyroid cancer	0.00428	0.0114	CbGpPWpGaD
Trifluridine—TK1—Metabolism—HPGD—thyroid cancer	0.00398	0.0106	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDK1—thyroid cancer	0.0039	0.0104	CbGpPWpGaD
Trifluridine—Nausea—Sorafenib—thyroid cancer	0.00376	0.0126	CcSEcCtD
Trifluridine—TYMP—Metabolism—NDUFA13—thyroid cancer	0.00364	0.00973	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.00345	0.00923	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CHST14—thyroid cancer	0.00342	0.00915	CbGpPWpGaD
Trifluridine—TYMS—Fluoropyrimidine Activity—TP53—thyroid cancer	0.0033	0.00883	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—PCM1—thyroid cancer	0.00309	0.00826	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—HPGD—thyroid cancer	0.00276	0.00737	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.00274	0.00733	CbGpPWpGaD
Trifluridine—Vision blurred—Epirubicin—thyroid cancer	0.0027	0.00903	CcSEcCtD
Trifluridine—Vision blurred—Doxorubicin—thyroid cancer	0.0025	0.00835	CcSEcCtD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	0.00231	0.00617	CbGpPWpGaD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00231	0.00617	CbGpPWpGaD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00231	0.00617	CbGpPWpGaD
Trifluridine—TK1—Metabolism—TPR—thyroid cancer	0.00229	0.00611	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PRKAR1A—thyroid cancer	0.00225	0.00601	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—MINPP1—thyroid cancer	0.00219	0.00585	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—TPR—thyroid cancer	0.00211	0.00564	CbGpPWpGaD
Trifluridine—Pain—Epirubicin—thyroid cancer	0.002	0.00669	CcSEcCtD
Trifluridine—TYMS—Cell Cycle—TPR—thyroid cancer	0.00189	0.00504	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—NDUFA13—thyroid cancer	0.00186	0.00498	CbGpPWpGaD
Trifluridine—Pain—Doxorubicin—thyroid cancer	0.00185	0.00619	CcSEcCtD
Trifluridine—TYMS—Metabolism—CHST14—thyroid cancer	0.00175	0.00468	CbGpPWpGaD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00173	0.00462	CbGpPWpGaD
Trifluridine—Hypersensitivity—Epirubicin—thyroid cancer	0.00172	0.00576	CcSEcCtD
Trifluridine—TK1—Metabolism—SLC5A5—thyroid cancer	0.00171	0.00457	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—PPARG—thyroid cancer	0.00166	0.00444	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CCND1—thyroid cancer	0.00162	0.00434	CbGpPWpGaD
Trifluridine—Hypersensitivity—Doxorubicin—thyroid cancer	0.00159	0.00533	CcSEcCtD
Trifluridine—TYMP—Metabolism—TPR—thyroid cancer	0.00158	0.00424	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PRKAR1A—thyroid cancer	0.00156	0.00417	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	0.00152	0.00406	CbGpPWpGaD
Trifluridine—TK1—Metabolism—RXRA—thyroid cancer	0.00144	0.00384	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDK1—thyroid cancer	0.00143	0.00382	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—HPGD—thyroid cancer	0.00141	0.00377	CbGpPWpGaD
Trifluridine—Nausea—Epirubicin—thyroid cancer	0.00139	0.00464	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.00136	0.00364	CbGpPWpGaD
Trifluridine—Nausea—Doxorubicin—thyroid cancer	0.00129	0.0043	CcSEcCtD
Trifluridine—TYMS—Cell Cycle—CDK1—thyroid cancer	0.00128	0.00342	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.00123	0.00329	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.00119	0.00317	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—SLC5A5—thyroid cancer	0.00119	0.00317	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00117	0.00313	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	0.00117	0.00313	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00115	0.00308	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—PTEN—thyroid cancer	0.00114	0.00305	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—RXRA—thyroid cancer	0.000996	0.00266	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—TERT—thyroid cancer	0.000921	0.00246	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000912	0.00244	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PPARG—thyroid cancer	0.000908	0.00243	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000878	0.00235	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—TPR—thyroid cancer	0.00081	0.00217	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.00081	0.00217	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PRKAR1A—thyroid cancer	0.000797	0.00213	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—TP53—thyroid cancer	0.000778	0.00208	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000737	0.00197	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PTGS2—thyroid cancer	0.000714	0.00191	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000684	0.00183	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PPARG—thyroid cancer	0.000629	0.00168	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PTEN—thyroid cancer	0.000623	0.00166	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SLC5A5—thyroid cancer	0.000607	0.00162	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CCND1—thyroid cancer	0.000596	0.00159	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CCND1—thyroid cancer	0.000532	0.00142	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—RXRA—thyroid cancer	0.00051	0.00136	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PTGS2—thyroid cancer	0.000495	0.00132	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PTEN—thyroid cancer	0.000432	0.00115	CbGpPWpGaD
Trifluridine—TK1—Metabolism—AKT1—thyroid cancer	0.000359	0.000959	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—TP53—thyroid cancer	0.000351	0.000938	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PPARG—thyroid cancer	0.000322	0.00086	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PTGS2—thyroid cancer	0.000253	0.000677	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—AKT1—thyroid cancer	0.000249	0.000665	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PTEN—thyroid cancer	0.000221	0.00059	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—AKT1—thyroid cancer	0.000127	0.00034	CbGpPWpGaD
